Gene silencing by methylation through a gene disruption that caused antisense transcription across the CpG island of the promoter was previously reported for HBA2 (alpha-thalassemia) and MLH1 (familial cancer syndrome)24–26. This evidence concerns the gene MLH1 and Alpha-thalassemia.